Buscar
01/10/2024
Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)
Andrés-Peiró, JV, Nomdedéu, J, Aguado, HJ, González-Morgado, D, Minguell-Monyart, J, Joshi-Jubert, N, Teixidor-Serra, J, Tomàs-Hernández, J, Selga-Marsà, J, García-Sánchez, Y, Noriega-González, DC, Mateos-Alvarez, E, Pereda-Manso, A, Cervera-Díaz, MC, Balvis-Balvis, P, García-Pérez, A, Rodríguez-Arenas, M, Castro-Menéndez, M, Moreta, J, Olías-López, B, Amaya-Espinosa, P, Boluda-Mengod, J, Bárcena-Goitilandia, L, Blas-Dobón, JA, Freile-Pazmiño, P, Castillón, P, Lanuza-Lagunilla, L, Cabria-Fernández, J, Valle-Cruz, J, García-Coiradas, J, Bonome-Roel, C, Cano-Leira, MD, Benjumea-Carrasco, A, Chico-García, M, Fernández-Juan, A, Saura-Sánchez, E, Sánchez-Gómez, P, Ricón-Recarey, FJ, García-García, EM, Medrano-Morte, I, Cuadrado-Abajo, F, Pérez-Núñez, MI, García-González, S, Del Pozo-Manrique, P, García-Navas-García, FM, García-Paredero, E, Guijarro-Valtueña, A, Navas-Pernía, I, Videla-Cés, M, Muñoz-Vives, JM, Querolt-Coll, J, de Santamaría, GTL, Serra-Porta, T, Carrasco-Becerra, MC, Pena-Paz, S, Otero-Naveiro, V, Fernández-Dorado, F, Martínez-Menduiña, A, Galián-Muñoz, E, Hernández, JM, Renau-Cerrillo, M, Campuzano-Bitterling, B, Carreras-Castañer, A, Vives-Barquiel, M, Camacho-Carrasco, P, Jornet-Gibert, M, Muñoz-Vicente, A, Gámez-Asunción, C, Plaza-Salazar, N, Benito-Santamaría, J, Cuenca-Copete, A, Alonso-Viana, L, Mingo-Robinet, J, Briso-Montiano, R, Barbería-Biurrun, A, Chouza-Montero, L, Ojeda-Thies, C, Ajuria-Fernández, E, Díaz-Suárez, R, Gasset-Teixidor, A, Domínguez-Ibarrola, A, Gosálbez, J, Pérez-Hevia, I, Riera-Alvarez, L, Roche-Albero, A, Macho-Mier, M, Criado-Albillos, G, Cabello-Benavides, HG, Cunchillos-Pascual, J, Saló-Cuenca, JC, Espona-Roselló, J, Salamanca-Ontiveros, C, García-Portabella, P, Blasco, JMI, Sevilla-Ortega, P, Cano-Porras, JR, Martínez-Díaz, S, Carabelli, GS, Slullitel, P, Astore, I, Hernández-Pascual, C, Marín-Sánchez, J, Córdova-Peralta, JC, Sánchez-Hernández, N, García-García, G, Rodríguez-Gangoso, A, Pérez-Sánchez, JM, Piñeiro-Borrero, A, Mandía-Martínez, A, De Caso-Rodríguez, J, Benito-Mateo, M, Murillo-Vizuete, AD, De La Herrán-Núnez, G, Nunes-Ugarte, N, Pérez-Salazar, NE, De Sande-Díaz, M, García-Fuentes, XD, de Cortázar-Antolín, UG, Sánchez, DE. Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS). INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. 2024; 55(10)DOI:10.1016/j.injury.2024.111715. PMID:39032221. IF:2.000(Q2/4D).
01/10/2024
Cardiovascular abnormalities in patients with SHANK3 pathogenic variants: Beyond neurodevelopmental disorders and epilepsy
Esmel-Vilomara, R, Miguel, LDD, Artigas-Baleri, A, Turón-Viñas, E, Cuscó, I, Díaz-Gómez, A, Panadés-De Oliveira, LPD, Rocamora, R, Boronat, S. Cardiovascular abnormalities in patients with SHANK3 pathogenic variants: Beyond neurodevelopmental disorders and epilepsy. European Journal of Medical Genetics. 2024; 71DOI:10.1016/j.ejmg.2024.104965. PMID:39094681. IF:1.700(Q3/8D).
01/10/2024
Generalizability of electroencephalographic interpretation using artificial intelligence: An external validation study
Mansilla, D, Tveit, J, Aurlien, H, Avigdor, T, Ros-Castello, V, Ho, ALY, Abdallah, C, Gotman, J, Beniczky, S, Frauscher, B. Generalizability of electroencephalographic interpretation using artificial intelligence: An external validation study. EPILEPSIA. 2024; 65(10)DOI:10.1111/epi.18082. PMID:39141002. IF:6.600(Q1/1D).
01/10/2024
IMPLEMENTATION OF CYP3 A5 GENOTYPING TO INDIVIDUALISE TACROLIMUS DOSE IN PAEDIATRIC PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION
Torija, IL, Mart n, LG, Sanz, PE, Armengol, PR, Chac n, CM, Noguera, SB, Espa ol, MT, Rodriguez, ER, Guerrero, SB, Mart nez, EFD. IMPLEMENTATION OF CYP3 A5 GENOTYPING TO INDIVIDUALISE TACROLIMUS DOSE IN PAEDIATRIC PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024
Clinical and Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Locally Advanced Lung Cancer
Otero, E, Gallego, P, Soto, A, Jornet, N, Rabi, S, Crespo, S, Calvet, G, Sanz, J, Martinez, S, Bermejo, S, Pardo, GS, Farré, N. Clinical and Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Locally Advanced Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2024; 120(2)DOI:. PMID:. IF:6.500(Q1/1D).
01/10/2024
Coinfection of monkeypox, COVID-19 and syphilis in a PrEP using MSM: A case report from Barcelona
Vives, A, Muñoz, CA, Alonso-Tarres, C, Cosentino, M. Coinfection of monkeypox, COVID-19 and syphilis in a PrEP using MSM: A case report from Barcelona. Actas Urologicas Espanolas. 2024; 48(8)DOI:10.1016/j.acuro.2024.04.001. PMID:38735435. IF:1.200(Q3/7D).
01/10/2024
Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial
Marcos, MC, de la Espriella, R, Comín-Colet, J, Zegrí-Reiriz, I, Gracia, JR, Morales-Rull, JL, Llàcer, P, Díez-Villanueva, P, Jiménez-Marrero, S, Bagudá, JD, Cortés, CO, Restrepo-Córdoba, MA, Goirigolzarri-Artaza, J, García-Pinilla, JM, Barrios, E, Díaz, SD, Hernández, EM, Sanchez-Marteles, M, Núñez, J. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26(10)DOI:10.1002/ejhf.3390. PMID:39056478. IF:10.800(Q1/1D).
01/10/2024
APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC
Provencio, M, Campos, B, Guirado, M, Vilà, L, Campelo, MRG, Dorta, M, Estévez, SV, Ferrandez, A, Sala, MA, Ortega, AL, Blasco, A, Insa, A, Areses, MC, Sullivan, I, Castro, RL, Calvo, V, Rodríguez -Abreu, D, Bosch-Barrera, J, López-Martín, A, Marsé, R, Torrado, L, Matskov, K, Giner, J, Bruno, MF, Saugar, ES, Martínez-Toledo, C, Cruz-Bermudez, A. APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).